Detalhe da pesquisa
1.
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro.
J Chem Inf Model
; 63(9): 2866-2880, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058135
2.
Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening.
Mem Inst Oswaldo Cruz
; 118: e230031, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672425
3.
COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.
Mem Inst Oswaldo Cruz
; 115: e200254, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33027420
4.
Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi.
Bioorg Med Chem
; 24(8): 1608-18, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26964673
5.
Efficient identification of novel anti-glioma lead compounds by machine learning models.
Eur J Med Chem
; 189: 111981, 2020 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978780
6.
Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings.
Expert Opin Drug Discov
; 14(12): 1269-1282, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416369
7.
Conservation analysis and decomposition of residue correlation networks in the phospholipase A2 superfamily (PLA2s): Insights into the structure-function relationships of snake venom toxins.
Toxicon
; 146: 50-60, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608922
8.
Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
Mem. Inst. Oswaldo Cruz
; 118: e230031, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1506732